Predictors of dyspnoea prevalence: Results from the BOLD study

European Respiratory Journal

Volumn 43, Issue 6, 2014, Pages 1610-1620

  Grnøseth, Rune ^a,b   Vollmer, William M ^c   Hardie, Jon A ^a,b   Ólafsdóttir, Inga Sif ^d   Lamprecht, Bernd ^e   Buist, A Sonia ^f   Gnatiuc, Louisa ^g   Gulsvik, Amund ^a,b   Johannessen, Ane ^b   Enright, Paul ^h  

^a UNIVERSITY OF BERGEN   (Norway)

^b HAUKELAND UNIVERSITY HOSPITAL   (Norway)

^c CENTER FOR HEALTH RESEARCH   (United States)

^d UPPSALA UNIVERSITY HOSPITAL   (Sweden)

^e PARACELSUS MEDICAL UNIVERSITY   (Austria)

^f OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^g IMPERIAL COLLEGE LONDON   (United Kingdom)

^h UNIVERSITY OF ARIZONA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE; ARTICLE; AUSTRALIA; AUSTRIA; BODY MASS; CANADA; CHINA; COMORBIDITY; CORRELATIONAL STUDY; CROSS-SECTIONAL STUDY; DIABETES MELLITUS; DISEASE ASSOCIATION; DYSPNEA; EDUCATIONAL STATUS; FEMALE; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; GEOGRAPHIC DISTRIBUTION; GERMANY; HEART DISEASE; HUMAN; HYPERTENSION; ICELAND; INDIA; LOW RISK POPULATION; LUNG SURGERY; MALE; NORWAY; PHILIPPINES; POLAND; PREDICTIVE VALUE; PREVALENCE; PRIORITY JOURNAL; SELF REPORT; SEX DIFFERENCE; SMOKING HABIT; SOUTH AFRICA; SPIROMETRY; SWEDEN; TUBERCULOSIS; TURKEY (REPUBLIC); UNITED KINGDOM; UNITED STATES; AGED; GEOGRAPHY; HEALTH SURVEY; INTERNATIONAL COOPERATION; LUNG DISEASES, OBSTRUCTIVE; MIDDLE AGED; ODDS RATIO; RISK FACTOR; SMOKING; VITAL CAPACITY;

ADULT; AGED; BODY MASS INDEX; CROSS-SECTIONAL STUDIES; DYSPNEA; FEMALE; FORCED EXPIRATORY VOLUME; GEOGRAPHY; HEALTH SURVEYS; HUMANS; INTERNATIONALITY; LUNG DISEASES, OBSTRUCTIVE; MALE; MIDDLE AGED; ODDS RATIO; PREVALENCE; RISK FACTORS; SMOKING; SPIROMETRY; VITAL CAPACITY;

EID: 84945173662     PISSN: 09031936     EISSN: 13993003     Source Type: Journal    
DOI: 10.1183/09031936.00036813     Document Type: Article

References (30)

1. Frostad A, Soyseth V, Andersen A, et al. Respiratory symptoms as predictors of all-cause mortality in an urban community: a 30-year follow-up. J Intern Med 2006; 259: 520-529.
2. The World Health Organization (WHO). The global burden of disease. 2004 update. Geneva, WHO Press, 2008 www.who.int/healthinfo/global-burden-disease/ 2004-report-update/en/. Date last accessed: October 4, 2011.
3. Bestall JC, Paul EA, Garrod R, et al. Usefulness of the Medical Research Council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary disease. Thorax 1999; 54: 581-586. (Pubitemid 29296676)
4. Steer J, Norman EM, Afolabi OA, et al. Dyspnoea severity and pneumonia as predictors of in-hospital mortality and early readmission in acute exacerbations of COPD. Thorax 2012; 67: 117-121.
5. Lindström M, Kotaniemi J, Jönsson E, et al. Smoking, respiratory symptoms, and diseases: a comparative study between northern Sweden and northern Finland: report from the FinEsS study. Chest 2001; 119: 852-861. (Pubitemid 32197659)
6. Eagan TM, Bakke PS, Eide GE, et al. Incidence of asthma and respiratory symptoms by sex, age and smoking in a community study. Eur Respir J 2002; 19: 599-605. (Pubitemid 34285154)
7. 1reduction and respiratory symptoms in the general population. Eur Respir J 2003; 21: 658-663.
8. Enright PL, Kronmal RA, Higgins MW, et al. Prevalence and correlates of respiratory symptoms and disease in the elderly. Cardiovascular Health Study. Chest 1994; 106: 827-834. (Pubitemid 24278891)
9. Hardie JA, Vollmer WM, Buist AS, et al. Respiratory symptoms and obstructive pulmonary disease in a population aged over 70 years. Respir Med 2005; 99: 186-195. (Pubitemid 40104273)
10. Variations in the prevalence of respiratory symptoms, self-reported asthma attacks, and use of asthma medication in the European Community Respiratory Health Survey (ECRHS). Eur Respir J 1996; 9: 687-695.
11. Lopez Varela MV, Montes de Oca M, Halbert RJ, et al. Sex-related differences in COPD in five Latin American cities: the PLATINO study. Eur Respir J 2010; 36: 1034-1041.
12. Gulsvik A. Prevalence of respiratory symptoms in the city of Oslo. Scand J Respir Dis 1979; 60: 275-285. (Pubitemid 10180538)
13. Hammond EC. Some preliminary findings on physical complaints from a prospective study of 1,064,004 men and women. Am J Public Health Nations Health 1964; 54: 11-23.
14. Menezes AM, Perez-Padilla R, Jardim JR, et al. Chronic obstructive pulmonary disease in five Latin American cities (the PLATINO study): a prevalence study. Lancet 2005; 366: 1875-1881. (Pubitemid 41690116)
15. Buist AS, Vollmer WM, Sullivan SD, et al. The Burden of Obstructive Lung Disease Initiative (BOLD): rationale and design. COPD 2005; 2: 277-283. (Pubitemid 40993302)
16. Brooks SM. Task group on surveillance for respiratory hazards in the occupational setting. ATS News 1982; 8: 12-16.
17. Standardization of Spirometry, 1994 Update. American Thoracic Society. Am J Respir Crit Care Med 1995; 152: 1107-1136.
18. Hankinson JL, Odencrantz JR, Fedan KB. Spirometric reference values from a sample of the general U.S. population. Am J Respir Crit Care Med 1999; 159: 179-187. (Pubitemid 29036522)
19. Hardin JW, Hilbe JM. Generalized Linear Models and Extensions. 2nd Edn. College Station, Stata Press, 2007.
20. Sunyer J, Basagana X, Roca J, et al. Relations between respiratory symptoms and spirometric values in young adults: the European community respiratory health study. Respir Med 2004; 98: 1025-1033. (Pubitemid 40029134)
21. O'Donnell DE, Ora J, Webb KA, et al. Mechanisms of activity-related dyspnea in pulmonary diseases. Respir Physiol Neurobiol 2009; 167: 116-132.
22. Burney PG, Hooper R. Forced vital capacity, airway obstruction and survival in a general population sample from the USA. Thorax 2011; 66: 49-54.
23. Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2013. The Global Stategy for the Diagnosis, Management and Prevention of COPD. Available from: http://www.goldcopd.org. Date last accessed: May 21, 2013. Date last updated: January 2014.
24. Duong M, Islam S, Rangarajan S, et al. Global differences in lung function by region (PURE): an international, community-based prospective study. Lancet Respir Med 2013; 1: 599-609.
25. Parshall MB, Schwartzstein RM, Adams L, et al. An official American Thoracic Society statement: update on the mechanisms, assessment, and management of dyspnea. Am J Respir Crit Care Med 2012; 185: 435-452.
26. Swinburn BA, Sacks G, Hall KD, et al. The global obesity pandemic: shaped by global drivers and local environments. Lancet 2011; 378: 804-814.
27. Quanjer PH, Stanojevic S, Cole TJ, et al. Multi-ethnic reference values for spirometry for the 3-95-yr age range: the global lung function 2012 equations. Eur Respir J 2012; 40: 1324-1343.
28. Burney PG, Hooper RL. The use of ethnically specific norms for ventilatory function in African-American and white populations. Int J Epidemiol 2012; 41: 782-790.
29. Abidov A, Rozanski A, Hachamovitch R, et al. Prognostic significance of dyspnea in patients referred for cardiac stress testing. N Engl J Med 2005; 353: 1889-1898. (Pubitemid 41565954)
30. Nishimura K, Izumi T, Tsukino M, et al. Dyspnea is a better predictor of 5-year survival than airway obstruction in patients with COPD. Chest 2002; 121: 1434-1440. (Pubitemid 34499652)